Q2 2024 · 13F-HR
ADAR1 Capital Management, LLCholdings as filed
Filed 2024-08-13 · accession 0001940267-24-000001
$529.7M
Reported value
266
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $55.6M | 10.5% | 1,603,932 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $46.3M | 8.73% | 853,862 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $43.9M | 8.28% | 4,150,009 | Common | SOLE |
| 02072L565 | BOXX | EA SERIES TRUST | $37.9M | 7.15% | 351,482 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $32.0M | 6.05% | 1,264,570 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $31.2M | 5.88% | 1,181,332 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $25.1M | 4.74% | 548,916 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $13.5M | 2.54% | 200,800 | PUT | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $12.6M | 2.38% | 476,543 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $10.2M | 1.92% | 3,289,260 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $10.1M | 1.90% | 150,000 | CALL | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $9.4M | 1.77% | 75,750 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $8.9M | 1.68% | 2,063,962 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $8.1M | 1.52% | 1,420,422 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $7.9M | 1.48% | 436,608 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $7.5M | 1.42% | 750,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $7.0M | 1.32% | 51,263 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $5.9M | 1.11% | 356,878 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $5.5M | 1.03% | 1,222,676 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $5.2M | 0.99% | 1,698,529 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $4.8M | 0.91% | 91,227 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $4.7M | 0.89% | 196,577 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $4.4M | 0.82% | 8,000 | PUT | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $4.1M | 0.78% | 404,138 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $3.9M | 0.74% | 155,799 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $3.8M | 0.72% | 93,350 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $3.4M | 0.63% | 74,850 | Common | SOLE |
| 78468R663 | BIL | SPDR SER TR | $3.0M | 0.56% | 32,500 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $2.8M | 0.53% | 42,217 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $2.8M | 0.53% | 156,504 | Common | SOLE |
| 00430K865 | — | ACASTI PHARMA INC | $2.8M | 0.53% | 959,571 | Common | SOLE |
| 92203C303 | VUSB | VANGUARD BD INDEX FDS | $2.7M | 0.52% | 55,206 | Common | SOLE |
| 46641Q837 | JPST | J P MORGAN EXCHANGE TRADED F | $2.7M | 0.51% | 54,000 | Common | SOLE |
| 464288679 | SHV | ISHARES TR | $2.7M | 0.51% | 24,500 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $2.7M | 0.50% | 663,598 | Common | SOLE |
| 68218J103 | OABI | OMNIAB INC | $2.7M | 0.50% | 712,560 | Common | SOLE |
| 97717Y527 | USFR | WISDOMTREE TR | $2.7M | 0.50% | 53,000 | Common | SOLE |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $2.5M | 0.48% | 542,233 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.3M | 0.43% | 253,197 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $2.3M | 0.43% | 368,369 | Common | SOLE |
| 483119202 | KALAEUR | KALA BIO INC | $2.2M | 0.41% | 306,067 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $2.1M | 0.40% | 114,309 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $2.1M | 0.39% | 50,200 | PUT | SOLE |
| 78467V707 | ULST | SSGA ACTIVE ETF TR | $1.9M | 0.36% | 47,684 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $1.7M | 0.32% | 72,800 | Common | SOLE |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC | $1.7M | 0.32% | 682,094 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $1.7M | 0.32% | 103,121 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $1.7M | 0.31% | 198,347 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $1.6M | 0.31% | 39,929 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $1.6M | 0.30% | 40,875 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $1.6M | 0.30% | 26,850 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $1.6M | 0.30% | 11,100 | Common | SOLE |
| 05153U107 | AURA | AURA BIOSCIENCES INC | $1.5M | 0.29% | 203,237 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $1.5M | 0.29% | 50,626 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $1.5M | 0.28% | 320,727 | Common | SOLE |
| 46090E103 | QQQ | INVESCO QQQ TR | $1.4M | 0.27% | 3,000 | PUT | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $1.3M | 0.24% | 645,161 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $1.3M | 0.24% | 138,158 | Common | SOLE |
| 451033708 | IBIO | IBIO INC | $1.2M | 0.23% | 570,000 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $1.2M | 0.23% | 918,929 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $1.1M | 0.21% | 70,007 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $1.1M | 0.21% | 39,950 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $1.1M | 0.20% | 201,728 | Common | SOLE |
| 87615L107 | TH | TARGET HOSPITALITY CORP | $989,682 | 0.19% | 113,626 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $981,920 | 0.19% | 34,000 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $979,000 | 0.18% | 110,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $928,872 | 0.18% | 53,261 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $924,998 | 0.17% | 12,250 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $890,400 | 0.17% | 60,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $886,712 | 0.17% | 195,311 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $882,360 | 0.17% | 38,000 | Common | SOLE |
| 03475V101 | ANGO | ANGIODYNAMICS INC | $870,365 | 0.16% | 143,862 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $862,488 | 0.16% | 32,400 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $827,082 | 0.16% | 35,180 | Common | SOLE |
| 05351W103 | AGREUR | AVANGRID INC | $817,190 | 0.15% | 23,000 | Common | SOLE |
| G52443101 | KVACU | KEEN VISION ACQUISITION CORP | $792,750 | 0.15% | 75,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $792,134 | 0.15% | 20,650 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $765,510 | 0.14% | 40,290 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $724,903 | 0.14% | 172,596 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $703,100 | 0.13% | 4,450 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $698,047 | 0.13% | 572,170 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $697,750 | 0.13% | 69,985 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $694,611 | 0.13% | 97,695 | Common | SOLE |
| 08862L103 | — | BEYOND AIR INC | $658,338 | 0.12% | 1,225,270 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $651,899 | 0.12% | 1,086,498 | Common | SOLE |
| 92243A200 | VXRT | VAXART INC | $630,978 | 0.12% | 945,568 | Common | SOLE |
| 22052L104 | CTVA | CORTEVA INC | $614,916 | 0.12% | 11,400 | Common | SOLE |
| G31659108 | — | ARYA SCIENCES ACQU CORP IV | $613,955 | 0.12% | 53,527 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $608,670 | 0.11% | 3,000 | PUT | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $598,394 | 0.11% | 25,507 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $593,750 | 0.11% | 5,000 | CALL | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $561,792 | 0.11% | 250,800 | Common | SOLE |
| 00507W206 | ATNM | ACTINIUM PHARMACEUTICALS INC | $555,984 | 0.10% | 75,133 | Common | SOLE |
| G89229119 | — | TMT ACQUISITION CORP | $549,000 | 0.10% | 50,000 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $543,000 | 0.10% | 12,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $533,780 | 0.10% | 13,000 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $518,700 | 0.10% | 70,000 | Common | SOLE |
| 00039J103 | YEAR | AB ACTIVE ETFS INC | $505,150 | 0.10% | 10,000 | Common | SOLE |
| 69344A107 | PULS | PGIM ETF TR | $497,000 | 0.09% | 10,000 | Common | SOLE |
| T9224W109 | STVN | STEVANATO GROUP S P A | $495,180 | 0.09% | 27,000 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $483,678 | 0.09% | 35,100 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $479,845 | 0.09% | 532,628 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $479,650 | 0.09% | 113,125 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $449,550 | 0.08% | 1,850 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $446,985 | 0.08% | 103,950 | Common | SOLE |
| 80105N105 | SNY | SANOFI | $441,532 | 0.08% | 9,100 | Common | SOLE |
| 88338N206 | TXMD | THERAPEUTICSMD INC | $434,958 | 0.08% | 270,160 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $409,914 | 0.08% | 246,936 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $405,674 | 0.08% | 12,850 | Common | SOLE |
| 75989R107 | RNXT | RENOVORX INC | $401,421 | 0.08% | 355,240 | Common | SOLE |
| 896945201 | TRIP | TRIPADVISOR INC | $391,820 | 0.07% | 22,000 | Common | SOLE |
| 62459M107 | — | MOVANO INC | $386,925 | 0.07% | 1,407,000 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $382,488 | 0.07% | 76,651 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $381,600 | 0.07% | 90,000 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $381,260 | 0.07% | 22,000 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $356,940 | 0.07% | 27,000 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $342,903 | 0.06% | 3,300 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $337,297 | 0.06% | 171,217 | Common | SOLE |
| 68404L201 | OPCH | OPTION CARE HEALTH INC | $332,400 | 0.06% | 12,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $330,554 | 0.06% | 7,891 | Common | SOLE |
| 384747101 | GRAL | GRAIL INC | $328,933 | 0.06% | 21,401 | Common | SOLE |
| 67190B104 | OAKU | OAK WOODS ACQUISITION CORP | $326,400 | 0.06% | 30,000 | Common | SOLE |
| 00211Y506 | ABIOEUR | ARCA BIOPHARMA INC | $324,309 | 0.06% | 84,676 | Common | SOLE |
| G5212E139 | — | JVSPAC ACQUISITION CORP | $312,600 | 0.06% | 30,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $296,782 | 0.06% | 25,366 | Common | SOLE |
| 955306105 | WST | WEST PHARMACEUTICAL SVSC INC | $293,157 | 0.06% | 890 | Common | SOLE |
| 29260Y109 | 0C3 | ENDEAVOR GROUP HLDGS INC | $286,923 | 0.05% | 10,615 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $270,832 | 0.05% | 21,060 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $267,247 | 0.05% | 202,460 | Common | SOLE |
| 55306N104 | MKSI | MKS INSTRS INC | $261,160 | 0.05% | 2,000 | Common | SOLE |
| 462837204 | — | IRON HORSE ACQUISITIONS CORP | $257,250 | 0.05% | 25,000 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $244,203 | 0.05% | 7,210 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $229,303 | 0.04% | 84,927 | Common | SOLE |
| 19239V302 | CCOI | COGENT COMMUNICATIONS HLDGS | $225,760 | 0.04% | 4,000 | Common | SOLE |
| 72201R882 | ZROZ | PIMCO ETF TR | $225,270 | 0.04% | 3,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $225,036 | 0.04% | 32,900 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $222,798 | 0.04% | 50,521 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $217,222 | 0.04% | 20,076 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $214,720 | 0.04% | 44,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $211,056 | 0.04% | 4,800 | Common | SOLE |
| 36151G600 | GBS1EUR | INTELLIGENT BIO SOLUTIONS IN | $207,840 | 0.04% | 108,250 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $203,881 | 0.04% | 107,306 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $199,440 | 0.04% | 55,400 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $183,895 | 0.03% | 355,216 | Common | SOLE |
| 464287432 | TLT | ISHARES TR | $183,560 | 0.03% | 2,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $183,253 | 0.03% | 4,700 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $181,692 | 0.03% | 29,400 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $179,648 | 0.03% | 22,400 | Common | SOLE |
| G4095J109 | GLRE | GREENLIGHT CAPITAL RE LTD | $162,244 | 0.03% | 12,385 | Common | SOLE |
| 67079A102 | — | NUVEI CORPORATION | $161,900 | 0.03% | 5,000 | Common | SOLE |
| 16934W106 | CMRXEUR | CHIMERIX INC | $156,129 | 0.03% | 178,229 | Common | SOLE |
| G1148A127 | BKHAU | BLACK HAWK ACQUISITION CORP | $154,800 | 0.03% | 15,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $153,341 | 0.03% | 5,900 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $151,803 | 0.03% | 50,601 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $147,395 | 0.03% | 18,634 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $141,596 | 0.03% | 12,020 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $141,532 | 0.03% | 89,014 | Common | SOLE |
| 70261F202 | KTTA | PASITHEA THERAPEUTICS CORP | $140,161 | 0.03% | 27,696 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $139,499 | 0.03% | 185,999 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $124,000 | 0.02% | 20,000 | CALL | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $123,592 | 0.02% | 5,988 | Common | SOLE |
| 269796108 | EGRX | EAGLE PHARMACEUTICALS INC | $123,200 | 0.02% | 22,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $107,500 | 0.02% | 10,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $104,080 | 0.02% | 8,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $102,150 | 0.02% | 15,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $99,960 | 0.02% | 12,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $99,428 | 0.02% | 5,589 | Common | SOLE |
| 29446K106 | EQ | EQUILLIUM INC | $97,585 | 0.02% | 140,775 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $97,308 | 0.02% | 20,400 | PUT | SOLE |
| G5251K103 | — | KENSINGTON CAPITAL ACQUISITI | $94,222 | 0.02% | 8,500 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $93,721 | 0.02% | 3,700 | CALL | SOLE |
| 071705107 | BLCO | BAUSCH PLUS LOMB CORP | $92,928 | 0.02% | 6,400 | Common | SOLE |
| 015857105 | AQN | ALGONQUIN PWR UTILS CORP | $87,900 | 0.02% | 15,000 | Common | SOLE |
| 34962G109 | TOCAEUR | FORTE BIOSCIENCES INC | $85,522 | 0.02% | 159,258 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $81,000 | 0.02% | 50,000 | Common | SOLE |
| 65445K200 | — | 99 ACQUISITION GROUP INC | $80,550 | 0.02% | 7,500 | Common | SOLE |
| G01490138 | — | AI TRANSN ACQUISITION CORP | $78,750 | 0.01% | 7,500 | Common | SOLE |
| 00773U207 | AVU0 | ADVERUM BIOTECHNOLOGIES INC | $77,518 | 0.01% | 11,300 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $77,030 | 0.01% | 46,685 | Common | SOLE |
| 53220K504 | LGND | LIGAND PHARMACEUTICALS INC | $74,991 | 0.01% | 890 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $73,045 | 0.01% | 3,500 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $71,490 | 0.01% | 1,500 | Common | SOLE |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $69,718 | 0.01% | 92,958 | Common | SOLE |
| 44267T102 | HHH | HOWARD HUGHES HOLDINGS INC | $64,820 | 0.01% | 1,000 | Common | SOLE |
| 606710200 | MITK | MITEK SYS INC | $62,608 | 0.01% | 5,600 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $59,533 | 0.01% | 1,516 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $51,750 | 0.01% | 2,500 | Common | SOLE |
| 90385V107 | UCTT | ULTRA CLEAN HLDGS INC | $49,000 | 0.01% | 1,000 | Common | SOLE |
| 500255104 | KSS | KOHLS CORP | $45,980 | 0.01% | 2,000 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $45,597 | 0.01% | 1,253 | Common | SOLE |
| G1933S101 | CASIF | CASI PHARMACEUTICALS INC | $45,320 | 0.01% | 8,240 | Common | SOLE |
| 30050E105 | EVO | EVOTEC AG | $45,120 | 0.01% | 9,400 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $44,536 | 0.01% | 5,560 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $44,330 | 0.01% | 11,000 | PUT | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $41,980 | 0.01% | 2,000 | Common | SOLE |
| 140755109 | CARAEUR | CARA THERAPEUTICS INC | $41,143 | 0.01% | 159,469 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $39,038 | 0.01% | 1,079 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $38,016 | 0.01% | 135,000 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $38,016 | 0.01% | 135,000 | PUT | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $37,600 | 0.01% | 2,000 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $37,590 | 0.01% | 1,500 | CALL | SOLE |
| 98987D300 | ZVSA | ZYVERSA THERAPEUTICS INC | $36,088 | 0.01% | 9,598 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $33,100 | 0.01% | 10,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $31,590 | 0.01% | 2,700 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $30,396 | 0.01% | 1,200 | PUT | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $29,926 | 0.01% | 12,955 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $28,548 | 0.01% | 200 | Common | SOLE |
| G97822103 | PRGO | PERRIGO CO PLC | $28,248 | 0.01% | 1,100 | Common | SOLE |
| 03209R103 | AMPH | AMPHASTAR PHARMACEUTICALS IN | $28,000 | 0.01% | 700 | Common | SOLE |
| 63001N106 | NATL | NCR ATLEOS CORPORATION | $27,020 | 0.01% | 1,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $25,350 | 0.00% | 600 | Common | SOLE |
| 62886E108 | VYX | NCR VOYIX CORPORATION | $24,700 | 0.00% | 2,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $24,150 | 0.00% | 300 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $22,932 | 0.00% | 1,400 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $22,875 | 0.00% | 7,500 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $21,571 | 0.00% | 1,850 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $21,125 | 0.00% | 1,300 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $20,852 | 0.00% | 1,300 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $20,150 | 0.00% | 5,000 | CALL | SOLE |
| 03212B103 | AMPY | AMPLIFY ENERGY CORP NEW | $19,852 | 0.00% | 2,928 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $19,000 | 0.00% | 10,000 | CALL | SOLE |
| 433000106 | HIMS | HIMS & HERS HEALTH INC | $18,979 | 0.00% | 940 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $18,018 | 0.00% | 20,000 | CALL | SOLE |
| 746237106 | PRTCY | PURETECH HEALTH PLC | $17,500 | 0.00% | 700 | Common | SOLE |
| G89229135 | — | TMT ACQUISITION CORP | $17,016 | 0.00% | 49,900 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $15,008 | 0.00% | 11,200 | Common | SOLE |
| 37962G128 | — | GLOBAL STAR ACQUISITION INC | $14,800 | 0.00% | 118,400 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $14,761 | 0.00% | 19,190 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $14,462 | 0.00% | 1,555 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $11,214 | 0.00% | 303 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $10,533 | 0.00% | 300 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $9,800 | 0.00% | 2,000 | Common | SOLE |
| 02156V109 | OKLO | OKLO INC | $8,470 | 0.00% | 1,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $7,799 | 0.00% | 100 | Common | SOLE |
| 67190B120 | OAKUR | OAK WOODS ACQUISITION CORP | $7,500 | 0.00% | 30,000 | Common | SOLE |
| 00654J206 | ADXN | ADDEX THERAPEUTICS LTD | $7,398 | 0.00% | 900 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $7,316 | 0.00% | 3,100 | Common | SOLE |
| 29446K106 | EQ | EQUILLIUM INC | $6,100 | 0.00% | 8,800 | CALL | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $5,905 | 0.00% | 6,000 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $5,658 | 0.00% | 600 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $5,519 | 0.00% | 100 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $5,418 | 0.00% | 100 | CALL | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $4,797 | 0.00% | 300 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $4,786 | 0.00% | 38 | Common | SOLE |
| G4740B105 | ICHR | ICHOR HOLDINGS | $4,163 | 0.00% | 108 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $4,150 | 0.00% | 2,500 | CALL | SOLE |
| 29772L108 | ETON | ETON PHARMACEUTICALS INC | $3,948 | 0.00% | 1,200 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $3,850 | 0.00% | 1,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $3,836 | 0.00% | 100 | CALL | SOLE |
| 68404V100 | — | OPTINOSE INC | $3,120 | 0.00% | 3,000 | Common | SOLE |
| 37962G110 | — | GLOBAL STAR ACQUISITION INC | $2,976 | 0.00% | 120,000 | Common | SOLE |
| 52886N406 | LEXX | LEXARIA BIOSCIENCE CORP | $2,627 | 0.00% | 945 | Common | SOLE |
| G3034H141 | EMCRF | EMBRACE CHANGE ACQUISITN COR | $2,484 | 0.00% | 18,000 | Common | SOLE |
| 31561T102 | AIEV | THUNDER PWR HLDGS INC | $2,475 | 0.00% | 1,500 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $2,250 | 0.00% | 1,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $2,153 | 0.00% | 100 | Common | SOLE |
| 15719Y121 | — | CETUS CAP ACQUISITION CORP | $1,424 | 0.00% | 4,999 | Common | SOLE |
| 98422T100 | — | XILIO THERAPEUTICS INC | $1,421 | 0.00% | 1,500 | Common | SOLE |
| 73245B115 | SBCWW | PONO CAP TWO INC | $1,406 | 0.00% | 19,800 | Common | SOLE |
| 67190B112 | — | OAK WOODS ACQUISITION CORP | $750 | 0.00% | 30,000 | Common | SOLE |
| 27877D112 | — | ECD AUTOMOTIVE DESIGN INC | $652 | 0.00% | 32,596 | Common | SOLE |
| 36119D111 | FTIIW | FUTURETECH II ACQUISITION CO | $483 | 0.00% | 30,000 | Common | SOLE |
| G3034H125 | EMCWF | EMBRACE CHANGE ACQUISITN COR | $378 | 0.00% | 18,000 | Common | SOLE |
| G0135E126 | AIMWF | AIMFINITY INVESTMENT CORP I | $362 | 0.00% | 18,000 | Common | SOLE |
| 35088F115 | FORLW | FOUR LEAF ACQUISITION CORP | $360 | 0.00% | 7,987 | Common | SOLE |
| 15719Y113 | — | CETUS CAP ACQUISITION CORP | $130 | 0.00% | 5,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.